The following are key points to remember from the European Association of Preventive Cardiology Position Statement on recommendations for participation in competitive and leisure sport in athletes ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock ...

The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule. The conversion factor for practitioners participating in a qualified ...

The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...

The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has ...

This page features ACC's full meeting coverage of the latest science from ACC.25 – including trial summaries, news stories, journal scans, videos and more.

The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule, updating the PFS conversion factor from $32.3465 to $33.5675 for qualifying ...

Roxana Mehran, MD, FACC, is an endowed professor of cardiovascular clinical research and outcomes and a professor of medicine (cardiology) and population health science and policy at the Icahn School ...

The ACC and AHA, in collaboration with several leading medical societies, have released a new clinical guideline focused on the management of adults with congenital heart disease (ACHD). The guideline ...

For more than 75 years, the ACC has been a trusted source of evidence-based cardiovascular guidance, delivering timely, actionable recommendations that support clinicians in providing optimal patient ...

The KRAKEN trial showed that among patients with high cardiovascular risk and elevated lipoprotein(a), muvalaplin reduces lipoprotein(a) levels. Patients with high cardiovascular risk and elevated ...

Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. 1 Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, ...